$1.64
0.000.00%
At close: -
$1.60
-0.04-2.44%
After Hours: Dec 19, 9:20 AM EDT
Comments
Loading...
PharmaCyte Biotech (NASDAQ:PMCB) Stock, Earnings Estimates, EPS, And Revenue
PharmaCyte Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Sep 17
EPS
$1.900
Quarterly Revenue
$0K
Annual Revenue
(as of Oct 31)
(as of Oct 31)
–
Analyze the earnings history of PharmaCyte Biotech using advanced sorting and filters.
Data brought to you by Benzinga APIs
PharmaCyte Biotech (PMCB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
PharmaCyte Biotech (PMCB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?
PharmaCyte Biotech (PMCB) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on September 17, 2024 for Q1.
What were the latest earnings per share (EPS) for PharmaCyte Biotech (NASDAQ:PMCB)?
The Actual EPS was $1.90, which beat the estimate of $0.00.
What were PharmaCyte Biotech’s (NASDAQ:PMCB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.